Which patients will respond to melanoma immunotherapy?
(Press-News.org) This news release is available in Japanese.
Patients with metastatic melanoma who have benefited from a new type of cancer immunotherapy don't appear to share the same tumor-produced antigens, according to a new report by Eliezer Van Allen and colleagues. If the molecular targets for the immunotherapy differ from patient to patient, as this study suggests, it may be difficult to predict which patients will respond to the treatment. The drug, called ipilimumab, is part of a relatively new class of cancer treatments called immune checkpoint inhibitors. The inhibitors help reactivate the immune system in tumors so that the body's natural defenses can detect and kill off cancer cells. Previous small studies have shown that the patients who do best with ipilimumab are those with tumors that contain many mutations, since these mutations produce a plethora of new antigen proteins that the immune system attacks as foreign invaders. In the biggest study to date, Van Allen and colleagues studied tumor tissue from over 100 patients with metastatic melanoma and confirmed that the patients with the most tumor "neoantigens" were also those most likely to respond positively to ipilimumab. However, only a very small percentage of these neoantigens were found in more than one patient who benefited from the drug.
Article #15: "Genomic correlates of response to CTLA4 blockade in metastatic melanoma," by E.M. Van Allen; D. Miao; S.A. Shukla; C.J. Wu; L.A. Garraway at Dana-Farber Cancer Institute in Boston, MA; E.M. Van Allen; D. Miao; S.A. Shukla; S. Gabriel; C.J. Wu; L.A. Garraway at Broad Institute of MIT and Harvard in Cambridge, MA; B. Schilling; L. Zimmer; A. Sucker; U. Hillen; D. Schadendorf at University Hospital, University Duisberg-Essen in Essen, Germany; B. Schilling; L. Zimmer; A. Sucker; U. Hillen; D. Schadendorf at German Cancer Consortium in Heidelberg, Germany; C. Blank; M.H. Geukes Foppen at Netherlands Cancer Institute in Amsterdam, Netherlands; S.M. Goldinger; R. Dummer at University Hospital Zurich in Zurich, Switzerland; J. Utikal at German Cancer Research Center in Heidelberg, Germany; J. Utikal at University Hospital Mannheim in Mannheim, Germany; J.C. Hassel at University Hospital Heidelberg in Heidelberg, Germany; B. Weide at University Hospital Tübingen in Tübingen, Germany; K.C. Kaehler at University Hospital Kiel in Kiel, Germany; C. Loquai at University Hospital Mainz in Mainz, Germany; P. Mohr at Elbe-Kliniken in Buxtehede, Germany; R. Gutzmer at University Hospital Hannover in Hannover, Germany.
ELSE PRESS RELEASES FROM THIS DATE:
This news release is available in Japanese.
The Southern Ocean has increased its uptake of atmospheric carbon dioxide again, after showing signs of slowing uptake in the 1990s, according to a new report from Peter Landschützer and colleagues. The Southern Ocean is a huge player in carbon sequestration, accounting for up to 40% of oceanic uptake of atmospheric carbon dioxide. When earlier studies showed the Southern Ocean's carbon sink weakening, the findings raised concerns that the planet might lose a powerful way to remove the growing amounts ...
Breathe in, breathe out, in, out... Like a giant lung, the Southern Ocean seasonally absorbs vast amounts of carbon dioxide (CO2) from the atmosphere and releases it back later in the year. But on an annual average the seas surrounding Antarctica absorb significantly more CO2 than they release. Most importantly, these seas remove a large part of the CO2 that human activities emit into the atmosphere, thereby slowing down the growth of this greenhouse gas in the atmosphere, lessening the rate of climate change. Although the Southern Ocean represents no more than a quarter ...
Berkeley -- To speed up progress in tackling climate change, policymakers need to build political support by investing in clean-energy industries rather than first penalizing polluters, according to a new policy paper by researchers at the University of California, Berkeley.
In the paper, to be published Thursday, Sept. 10, in the journal Science, a multidisciplinary team of environmental, political and legal experts finds that instead of emphasizing cap-and-trade schemes and penalties on greenhouse gas emissions - strategies considered to be most efficient by many economists ...
MENLO PARK, Calif. -- Some of the inner workings of Earth's subduction zones and their "megathrust" faults are revealed in a paper published today in the journal Science. U.S. Geological Survey scientist Jeanne Hardebeck calculated the frictional strength of subduction zone faults worldwide, and the stresses they are under. Stresses in subduction zones are found to be low, although the smaller amount of stress can still lead to a great earthquake.
Subduction zone megathrust faults produce most of the world's largest earthquakes. The stresses are the forces acting on ...
Researchers from the MRC Centre for Developmental Neurobiology (MRC CDN) at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, have discovered a new molecular 'switch' that controls the properties of neurons in response to changes in the activity of their neural network. The findings, published in Science, suggest that the 'hardware' in our brain is tuneable and could have implications that go far beyond basic neuroscience - from informing education policy to developing new therapies for neurological disorders such as epilepsy.
WASHINGTON, D.C. - Since 2002, the Southern Ocean has been removing more of the greenhouse gas carbon dioxide from the atmosphere, according to two new studies.
These studies make use of millions of ship-based observations and a variety of data analysis techniques to conclude that that the Southern Ocean has increasingly taken up more carbon dioxide during the last 13 years. That follows a decade from the early 1990s to 2000s, where evidence suggested the Southern Ocean carbon dioxide sink was weakening. The new studies appear today in the American Geophysical Union ...
A prospective longitudinal study of U.S. Marines suggests that reduced heart rate variability - the changing time interval between heartbeats - may be a contributing risk factor for post-traumatic stress disorder (PTSD). The findings are reported in the September 9 online issue of JAMA Psychiatry by researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System.
Even at rest, the normal rhythm of the heart fluctuates, reflecting influences and changes in other parts of the body. Generally speaking, the greater ...
Imagine the scientific discoveries that would result from a searchable online database containing millions of plant, algae, and fungi specimen records. Thanks to a new set of workflow modules to digitize specimen collections currently preserved in herbaria, something like that might be within reach. The modules are provided by the National Science Foundation's (NSF) Integrated Digitized Biocollections (iDigBio), which is facilitating a collective effort to unify digitization projects across the nation.
"North America's herbaria curate approximately 74 million specimens ...
COLUMBUS, Ohio - Would a color by any other name be thought of in the same way, regardless of the language used to describe it?
According to new research, the answer is yes.
A new study examines how a culture of nomadic hunter-gatherers names colors, and shows that they group colors into categories that align with patterns of color grouping evident in 110 other world languages.
This study population - the Hadza people of Tanzania - has relatively few commonly shared color words in its language. During the study, the most common response by Hadza participants to a ...
Seasonal flare-ups in patients with multiple sclerosis are caused by plummeting levels of melatonin in the spring and summer, according to research published September 10 in Cell. The study reveals that relapses in patients with this autoimmune disorder are much less frequent in the fall and winter, when levels of the so-called darkness hormone are at their highest, but the reverse is true in the spring and summer seasons.
Moreover, treatment with melatonin improved clinical symptoms in a mouse model of multiple sclerosis by restoring a healthy balance of immune cells ...
LAST 30 PRESS RELEASES: